These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4469807)

  • 41. [Chlorbutin, azathioprine, d-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis patients. III. A comparative analysis of their effect on the morphological manifestations of synovitis based on puncture biopsy data].
    Shekhter AB; Krel' AA; Chichasova NV; Rashchupkina ZP
    Ter Arkh; 1984; 56(2):121-31. PubMed ID: 6710393
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapeutic efficiency of penicillamine D in rheumatic arthritis].
    Robles Gil J
    Arch Inst Cardiol Mex; 1979; 49(4):685-91. PubMed ID: 485674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long-term treatment of chronic progredient polyarthritis with D-penicillamine].
    Hagemann D; Frankl R
    Med Welt; 1969 Aug; 35():1920-3. PubMed ID: 5809869
    [No Abstract]   [Full Text] [Related]  

  • 44. [Penicillamine (dimethylcysteine, DISTA) in rheumatoid arthritis].
    Hansen TM; Lorenzen I
    Ugeskr Laeger; 1977 Feb; 139(7):407-8. PubMed ID: 320736
    [No Abstract]   [Full Text] [Related]  

  • 45. [Basic therapy of rheumatoid arthritis with D-penicillamine. Personal contribution and critical observations].
    Gigante D; Teodori S; Crispo M
    Fortschr Med; 1983 Apr; 101(13):613-8. PubMed ID: 6852728
    [No Abstract]   [Full Text] [Related]  

  • 46. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
    Carter H; Job-Deslandre C; Delrieu F; Menkes CJ
    Therapie; 1984; 39(6):689-95. PubMed ID: 6531741
    [No Abstract]   [Full Text] [Related]  

  • 47. Eosinophilia in rheumatoid patients treated with D-penicillamine.
    Edelman J; Maguire KF; Owen ET
    J Rheumatol; 1984 Oct; 11(5):624-5. PubMed ID: 6512792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Penicillamine and rheumatoid arthritis. Recent research results].
    Aaseth J; Munthe E; Jellum E
    Tidsskr Nor Laegeforen; 1980 Jan; 100(1):3-6. PubMed ID: 7368189
    [No Abstract]   [Full Text] [Related]  

  • 49. [Long-term treatment of chronic rheumatoid arthritis with D-penicillamin (author's transl)].
    Tausch G; Bröll H; Eberl R
    Schweiz Rundsch Med Prax; 1977 Nov; 66(45):1427-30. PubMed ID: 412181
    [No Abstract]   [Full Text] [Related]  

  • 50. Recurrent episodes of pseudoseptic arthritis in rheumatoid arthritis: response to D-penicillamine and methotrexate.
    Hunter T
    J Rheumatol; 1992 Sep; 19(9):1484. PubMed ID: 1433023
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of infectious non-specific polyarthritis with D-penicillamine (preliminary report)].
    Krikunov VP
    Vopr Revm; 1971; 11(4):24-6. PubMed ID: 5140693
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of the usefulness of delayed-action preparations in the treatment of rheumatoid polyarthritis by analyzing the therapeutic maintenance dose].
    Dougados M; Nguyen M; Duchesne L; Benjelloun M; Amor B
    Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):89-92. PubMed ID: 2727586
    [No Abstract]   [Full Text] [Related]  

  • 53. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes].
    Zborovskiĭ AB; Sivordova LE; Derevianko LI; Zborovskaia IA; Zavodovskiĭ BV
    Ter Arkh; 1999; 71(1):60-3. PubMed ID: 10097305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [D-penicillamine therapy of chronic polyarthritis].
    Günther R; Gabl F; Knapp E
    Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805
    [No Abstract]   [Full Text] [Related]  

  • 56. A controlled trial of penicillamine in rheumatoid arthritis.
    Thomas MH; Rothermich NO; Philips VK; Bergen W
    Ohio State Med J; 1979 Aug; 75(8):497-500. PubMed ID: 382010
    [No Abstract]   [Full Text] [Related]  

  • 57. [Zinc levels in blood and urine of rheumatoid arthritis patients after four months treatment with D-penicillamine].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Z Rheumatol; 1980; 39(11-12):395-400. PubMed ID: 7282103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Good response to D-penicillamine in IgA-deficient rheumatoid arthritis.
    Mbuyi-Muamba JM; Stevens E; Dequeker J
    Scand J Rheumatol; 1981; 10(1):31-2. PubMed ID: 7221493
    [No Abstract]   [Full Text] [Related]  

  • 59. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
    Pickup ME; Dixon JS; Lowe JR; Wright V
    J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes in various humoral immunity indicators during the treatment of rheumatoid arthritis with D-penicillamine (cuprenil)].
    Chwalińska-Sadowska H; Małdykowa H; Zajaczek-Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Swierczyńska Z; Orłowska G; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1981; 19(2):151-7. PubMed ID: 6459630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.